CD274 and neoplasm: Further studies revealed that baicalein and baicalin significantly inhibited IFN-γ-induced cellular PD-L1 upregulation thereby increasing T-cell-mediated tumor-killing activity in addition to dose-dependently and directly inhibiting proliferation of SMMC-7721 and HepG2 cell.